| BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
| HOXC@ |
|
homeobox C cluster
|
|
|
0.695 |
0.462 |
| HOXD@ |
|
homeobox D cluster
|
|
|
0.631 |
0.538 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| LEPQTL1 |
|
Leptin, serum levels of
|
|
|
0.638 |
0.385 |
| SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| SNHG3 |
|
small nucleolar RNA host gene 3
|
|
|
0.682 |
0.385 |
| MMP23A |
|
matrix metallopeptidase 23A (pseudogene)
|
|
|
0.722 |
0.308 |
| DLEU2 |
|
deleted in lymphocytic leukemia 2
|
|
|
0.650 |
0.500 |
| KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
| PTENP1 |
|
phosphatase and tensin homolog pseudogene 1
|
|
|
0.650 |
0.577 |
| TDGF1P6 |
|
teratocarcinoma-derived growth factor 1 pseudogene 6
|
|
|
0.659 |
0.577 |
| SNHG1 |
|
small nucleolar RNA host gene 1
|
|
|
0.576 |
0.692 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| DGCR5 |
|
DiGeorge syndrome critical region gene 5
|
|
|
0.650 |
0.577 |